PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Karuna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 10:03 am Sale |
2023-12-31 | 13G | Karuna Therapeutics, Inc. KRTX |
PRICE T ROWE ASSOCIATES INC | 1,963,957 5.200% |
-399,347 (-16.90%) |
Filing |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Karuna Therapeutics, Inc. KRTX |
PRICE T ROWE ASSOCIATES INC | 2,363,304 6.900% |
407,938 (+20.86%) |
Filing |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Karuna Therapeutics, Inc. KRTX |
PRICE T ROWE ASSOCIATES INC | 1,955,366 6.600% |
531,205 (+37.30%) |
Filing |
| 2021-02-16 12:24 pm Purchase |
2020-12-31 | 13G | Karuna Therapeutics, Inc. KRTX |
PRICE T ROWE ASSOCIATES INC | 1,424,161 5.300% |
1,424,161 (New Position) |
Filing |